文献速递关节外科运动医学

超声引导腱表面注射促进冻结肩快速功能恢复:多中心随机试验

A Novel Ultrasound-Guided Injection Strategy for Rapid Functional Recovery in Frozen Shoulder: A Multicenter Randomized Trial.
PubMed 文献 · Am J Sports Med · 2026-03-18

该多中心随机对照试验纳入139例冻结肩患者,比较超声引导腱表面注射(UGTS)、局麻下手法松解(MULA)和盲痛点注射(BTP),均联合关节内注射与家庭锻炼。UGTS组在1周时BFHS评分改善更快,1个月完全缓解率59.2%高于BTP的31.0%和MULA的34.9%,24个月时三组缓解率趋同,且未观察到软骨厚度显著影响或肩袖损伤。

要点

  • UGTS联合关节内注射与锻炼在1周时即显现肩功能快速改善。
  • UGTS组1个月完全缓解率59.2%,高于BTP的31.0%和MULA的34.9%。

核心结论

  • UGTS联合关节内注射与锻炼可促进冻结肩更快恢复且无安全性担忧,可作为快速缓解的非侵入性一线选择。

研究设计与样本

  • 多中心随机对照试验,证据等级1级,2019—2022年开展;筛查365例,纳入139例,随机分为UGTS组49例、MULA组43例、BTP组47例。

主要发现

  • 1周随访时UGTS组BFHS评分较MULA和BTP组快速改善,VAS评分、ROM、ESSU评分和疼痛缓解也支持早期功能优势。
  • UGTS组完全缓解率1个月为59.2%(BTP 31.0%、MULA 34.9%),3个月为79.6%(BTP 53.2%、MULA 69.8%),差异有统计学意义(P<.05)。
  • 24个月时三组完全缓解率趋同(P=.216),UGTS对关节软骨厚度无显著影响,连续超声监测未发现归因于UGTS操作或锻炼的肩袖损伤。

关键数值与推荐

  • 主要结局为4周肩功能,采用北京友谊医院量表(BFHS)评估。
  • 次要结局包括1个月VAS疼痛评分、主动ROM、超声下肩关节评估量表(ESSU)评分、疼痛缓解、治疗次数、软骨厚度及2年完全缓解率(电话随访)。

临床怎么用

  • 对于寻求快速缓解的冻结肩患者,可考虑UGTS联合关节内注射与家庭锻炼作为非侵入性一线方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current frozen shoulder (FS) therapies present a clinical dilemma: although intra-articular corticosteroids with home exercise provide proven medium-term (3-month) benefits, they lack short-term (<4-week) efficacy for rapid recovery; conversely, manipulative treatments achieve faster outcomes but carry invasiveness risks. These limitations highlight the urgent need for developing and validating novel noninvasive approaches with prompt therapeutic effects. PURPOSE: To compare the efficacy and safety of ultrasound-guided tendon surface (UGTS) injection versus manipulation under local anesthesia (MULA) and blind tender point (BTP) injection, all combined with intra-articular injection and home exercise. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: The authors first developed a novel ultrasound-based strategy, which they named "ultrasound-guided tendon surface." Then they conducted a multicenter randomized controlled trial (2019-2022). The primary outcome was 4-week shoulder function assessed by the Beijing Friendship Hospital Scale (BFHS), a modified version of the Constant-Murley Score adapted for Chinese populations with demonstrated validity. Secondary outcomes included (1) short-term (1-month) pain (visual analog scale [VAS]) score, active range of motion (ROM), Evaluation Scale of the Shoulder under Ultrasound (ESSU) score, pain relief, treatment sessions, and cartilage thickness; and (2) long-term (2-year) complete remission rates (tele-follow-up). RESULTS: Among 365 screened patients, 139 were enrolled and randomized to receive UGTS (n = 49), MULA (n = 43), and BTP (n = 47). At the 1-week follow-up visit, the UGTS group showed rapid improvement in BFHS scores compared to both the MULA and BTP groups. These early functional advantages were also indicated by the VAS score, ROM, ESSU score, and pain relief. UGTS achieved faster complete remission (1 month: 59.2% vs 31.0% and 34.9% for BTP and MULA, respectively; 3-month: 79.6% vs 53.2% and 69.8% for BTP and MULA, respectively; P < .05), with remission rates converging by 24 months (P = .216), yet retained early rapid response as its key clinical advantage. UGTS showed no significant impact on articular cartilage thickness. Serial ultrasound monitoring demonstrated no rotator cuff injuries attributable to either the UGTS procedure or prescribed exercises. CONCLUSION: UGTS combined with intra-articular injection and exercise promotes faster recovery without safety concerns, representing an effective noninvasive first-line option for rapid relief in FS. REGISTRATION: ChiCTR1900025874 (Chinese Clinical Trial Registry number).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Zhu D, Ou Y, Li Y, et al. A Novel Ultrasound-Guided Injection Strategy for Rapid Functional Recovery in Frozen Shoulder: A Multicenter Randomized Trial. Am J Sports Med. 2026. PMID: 41846416. doi:10.1177/03635465261427347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。